CCA
ALXN

Canyon Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Canyon Capital Advisors’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-450,000
Closed -$82.7M – 130
2021
Q2 		$82.7M Hold
450,000
– – 3.07% 8
2021
Q1 		$68.8M Buy
+450,000
New +$68.8M 2.73% 7